STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 279 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.

Quarter-by-quarter ownership
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$796,128
-22.1%
25,178
+0.5%
0.00%0.0%
Q2 2023$1,021,457
+16.8%
25,048
+6.8%
0.00%0.0%
Q1 2023$874,280
+6.8%
23,4580.0%0.00%0.0%
Q4 2022$818,450
-41.2%
23,458
-5.6%
0.00%
-50.0%
Q3 2022$1,391,000
+1.4%
24,858
-6.2%
0.00%
+33.3%
Q2 2022$1,372,000
-19.2%
26,508
+13.5%
0.00%0.0%
Q1 2022$1,697,000
-37.7%
23,348
+1.4%
0.00%
-40.0%
Q4 2021$2,723,000
-16.6%
23,028
-5.3%
0.01%
-16.7%
Q3 2021$3,264,000
-8.5%
24,328
+10.5%
0.01%
-14.3%
Q2 2021$3,566,000
+126.3%
22,024
+12.1%
0.01%
+133.3%
Q1 2021$1,576,000
+49.5%
19,638
+1.3%
0.00%
+50.0%
Q4 2020$1,054,000
+223.3%
19,378
+18.0%
0.00%
+100.0%
Q3 2020$326,000
-1.2%
16,418
+4.7%
0.00%0.0%
Q2 2020$330,000
+117.1%
15,678
+26.3%
0.00%
Q1 2020$152,000
-81.2%
12,412
-77.5%
0.00%
-100.0%
Q4 2019$808,000
-7.4%
55,056
-15.8%
0.00%0.0%
Q3 2019$873,000
+330.0%
65,391
+426.8%
0.00%
+100.0%
Q2 2019$203,000
-13.2%
12,412
+51.8%
0.00%0.0%
Q3 2018$234,000
+15.3%
8,178
+10.2%
0.00%0.0%
Q2 2018$203,0007,4180.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Discovery Value Fund 561,561$17,756,5599.73%
MPM BioImpact LLC 544,639$17,221,4854.60%
Casdin Capital, LLC 1,178,075$37,250,7324.12%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,145,091$36,207,7773.72%
Atlas Venture Associates IX, LLC 10,000$316,2002.69%
Deep Track Capital, LP 2,000,000$63,240,0002.44%
ARK Investment Management 9,948,629$314,575,6382.41%
Merlin Capital, Inc 18,526$585,7922.19%
Orchard Capital Management, LLC 159,155$5,032,4811.86%
TANG CAPITAL MANAGEMENT LLC 397,600$12,572,1121.77%
View complete list of INTELLIA THERAPEUTICS INC shareholders